fashion -WSS

fashion

author：Wikipedia 2025-09-28 21:58:00 - browse：84

Illustration of three connected puzzle pieces, with a woman standing near the missing/empty puzzle piece space. -- first opinion coverage from STAT — Adobe

Women have always been underrepresented in medical research. A new study reveals that not much has changed, especially when it comes to tests of cardiovascular devices.

In a paper published in JAMA Internal Medicine on Monday, researchers found that the percentage of women represented in high-risk medical device trials did not increase from 2010 to 2020. Women generally made up just 33% of participants when the team reviewed 195 trials published from 2016 to 2022. The percentages varied between devices: Women made up 46% of participants in orthopedic trials, but 29% in cardiovascular studies.

The issue isn’t new. The government has made some strides in correcting earlier missteps, like the Food and Drug Administration telling researchers in 1977 to exclude women of reproductive potential from early clinical trials. But stakeholders think agencies like the FDA could do more to incentivize the enrollment of women.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Readout Newsletter: Amgen, Regeneron, BGI Group and more

WSS

Surgery pushed Ben Carson to fame

Will Ozempic

STAT Summit: Michael J. Fox on progress in Parkinson's research

Texas Medical Board asked to define abortion emergency exception

Bernie brings in new pharma CEOs to talk drug prices

The EU Joint Clinical Assessment needs to live up to its promise

entertainment

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

focus

Medical records are filled with copy

STAT Summit: How a Chicago ER doctor tackles gun violence

As demand for Covid shots wanes, Moderna seeks its next success

Eli Lilly expects to double planned employment in Boston center

Bright Health sells Medicare Advantage business to Molina

Surgery pushed Ben Carson to fame

Malaria cases in Florida and Texas: Here’s what you need to know

The CDC's new social media misinformation war

Medicare proposal to cover medical devices draws a mixed reaction

STAT Summit: Biotech founders on deal

hotspot

Beam Therapeutics to lay off 20% of its staff, re

Johnson & Johnson sued for allegedly overpaying for workers' drugs

Cano Health’s bankruptcy is a warning for Medicare Advantage

NIH confirmation hearing shows politicization of research

HHS leader on health, climate change and biopharma emissions

Why health workers in Gaza are injured or die at high rates

Wikipedia

entertainment

focus

focus